186 related articles for article (PubMed ID: 8605355)
21. Hydrocortisone differentially affects the ability of murine stromal cells and human marrow-derived adherent cells to promote the differentiation of CD34++/CD38- long-term culture-initiating cells.
Croisille L; Auffray I; Katz A; Izac B; Vainchenker W; Coulombel L
Blood; 1994 Dec; 84(12):4116-24. PubMed ID: 7527666
[TBL] [Abstract][Full Text] [Related]
22. MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.
Liesveld JL; Harbol AW; Belanger T; Rosell KE; Abboud CN
Blood Cells Mol Dis; 2000 Aug; 26(4):261-75. PubMed ID: 11042027
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of interleukin-3, interleukin-7, interleukin 15, and granulocyte-macrophage colony-stimulating factor in the generation of natural killer and B cells from primitive human fetal liver progenitors.
Muench MO; Humeau L; Paek B; Ohkubo T; Lanier LL; Albanese CT; Bárcena A
Exp Hematol; 2000 Aug; 28(8):961-73. PubMed ID: 10989197
[TBL] [Abstract][Full Text] [Related]
24. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo.
Civin CI; Almeida-Porada G; Lee MJ; Olweus J; Terstappen LW; Zanjani ED
Blood; 1996 Dec; 88(11):4102-9. PubMed ID: 8943843
[TBL] [Abstract][Full Text] [Related]
25. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells.
Gan OI; Murdoch B; Larochelle A; Dick JE
Blood; 1997 Jul; 90(2):641-50. PubMed ID: 9226164
[TBL] [Abstract][Full Text] [Related]
26. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells.
Sakai A; Fujii T; Noda M; Hyodo H; Oda K; Kimura A
Am J Hematol; 1996 Dec; 53(4):251-3. PubMed ID: 8948665
[TBL] [Abstract][Full Text] [Related]
27. Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-beta1 by bone marrow stromal cells.
Papadaki HA; Giouremou K; Eliopoulos GD
Eur J Haematol; 1999 Sep; 63(3):154-62. PubMed ID: 10485270
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta1 down-regulates expression of chemokine stromal cell-derived factor-1: functional consequences in cell migration and adhesion.
Wright N; de Lera TL; García-Moruja C; Lillo R; García-Sánchez F; Caruz A; Teixidó J
Blood; 2003 Sep; 102(6):1978-84. PubMed ID: 12775566
[TBL] [Abstract][Full Text] [Related]
29. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
[TBL] [Abstract][Full Text] [Related]
30. Differential use of very late antigen-4 and -5 integrins by hematopoietic precursors and myeloma cells to adhere to transforming growth factor-beta1-treated bone marrow stroma.
Robledo MM; Sanz-Rodriguez F; Hidalgo A; Teixidó J
J Biol Chem; 1998 May; 273(20):12056-60. PubMed ID: 9575147
[TBL] [Abstract][Full Text] [Related]
31. Identification of immature and mature myeloma cells in the bone marrow of human myelomas.
Kawano MM; Huang N; Harada H; Harada Y; Sakai A; Tanaka H; Iwato K; Kuramoto A
Blood; 1993 Jul; 82(2):564-70. PubMed ID: 8329711
[TBL] [Abstract][Full Text] [Related]
32. In vitro identification of single CD34+CD38- cells with both lymphoid and myeloid potential.
Hao QL; Smogorzewska EM; Barsky LW; Crooks GM
Blood; 1998 Jun; 91(11):4145-51. PubMed ID: 9596660
[TBL] [Abstract][Full Text] [Related]
33. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
[TBL] [Abstract][Full Text] [Related]
35. Ligation of CD38 suppresses human B lymphopoiesis.
Kumagai M; Coustan-Smith E; Murray DJ; Silvennoinen O; Murti KG; Evans WE; Malavasi F; Campana D
J Exp Med; 1995 Mar; 181(3):1101-10. PubMed ID: 7869031
[TBL] [Abstract][Full Text] [Related]
36. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.
Gazitt Y; Reading CC; Hoffman R; Wickrema A; Vesole DH; Jagannath S; Condino J; Lee B; Barlogie B; Tricot G
Blood; 1995 Jul; 86(1):381-9. PubMed ID: 7540887
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo expansion of CD34 + CD38- cord blood cells.
De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; De Hemptinne D; Stryckmans P
J Hematother; 1997 Apr; 6(2):93-102. PubMed ID: 9131438
[TBL] [Abstract][Full Text] [Related]
38. Anti-CD38-blocked ricin: an immunotoxin for the treatment of multiple myeloma.
Goldmacher VS; Bourret LA; Levine BA; Rasmussen RA; Pourshadi M; Lambert JM; Anderson KC
Blood; 1994 Nov; 84(9):3017-25. PubMed ID: 7524764
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
[TBL] [Abstract][Full Text] [Related]
40. Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19+ B-cell precursors by an anti-CD19 pan-B-cell immunotoxin containing pokeweed antiviral protein.
Uckun FM; Haissig S; Ledbetter JA; Fidler P; Myers DE; Kuebelbeck V; Weisdorf D; Gajl-Peczalska K; Kersey JH; Ramsay NK
Blood; 1992 Jun; 79(12):3369-79. PubMed ID: 1375851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
